MabCampath

Made by

• Sanofi

Active Ingredient

Alemtuzumab

Prospectus

Approval date

2014/9/26

Treats

• Chronic lymphocytic leukemia

Dosages

• MabCampath I.V.Infusion - 90907円／瓶